ARBs to be tested over contamination concerns
The move from the TGA follows the withdrawal of two valsartan brands last year
The TGA is testing a range of ARB medications for contamination following the recall of two valsartan brands last year.
Mylan and Apotex withdrew their valsartan products after regulators found they were contaminated with N-nitrosodiethylamine, a probable carcinogen but one that is common in cured meats or air pollution.
